Assessing and communicating breast cancer prognosis
Web appendix 1 Search strategy per database Source
Search terms
Web of Science
TS=((“personalized medicine” OR “Individualized medicine” OR “Personalized medicine” OR “decision support system” OR “Decision Support Techniques” OR “prognostic model” OR “prognostic software model” OR “Prognostication” OR “decision aid” OR “individualized risk information” OR “patient-specific decision aid” OR “decision aids” OR ((“therapeutic efficacy” OR “therapeutic resistance” OR “prognosis” OR “Prognostic” OR “Predictive” OR “Predictor” OR “Predictors” OR “Prediction” OR “Predictions” OR “Predict” OR “Predicts” OR “Decision” OR “Decide” OR “Decides”) AND (“tool” OR “tools” OR “molecular”)) OR “OncotypeDX” OR “oncotype dx” OR “21-gene assay” OR “70-gene signature” OR “mammaprint” OR “Predict” OR “nomogram” OR “PAM50” OR “MapQuant Dx” OR “Theros Breast cancer Index SM” OR “BLN assay” OR “Arup breast bioclassifier” OR “Celera Metastatic Score” OR “Exagen Breast cancer tm” OR “Invasive gene signature” OR “Mammostrat” OR “EpiDoc” OR “Van Nuys prognostic index” OR “VNPI” OR “Genomic grade index” OR “GGI”) AND (“breast tumor” OR ((“breast”) AND (“neoplasms” OR “neoplasm” OR “cancer” OR “tumor” OR “tumour” OR “tumors” OR “tumours” OR “malignancy” OR “malignancies”))) AND “adjuvant therapy”)
59
2